AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
1-Year Return 29.75%
This Quarter Return
+14.73%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$676M
AUM Growth
+$37.5M
Cap. Flow
-$29.2M
Cap. Flow %
-4.32%
Top 10 Hldgs %
50.78%
Holding
109
New
10
Increased
20
Reduced
23
Closed
14

Top Buys

1
INSM icon
Insmed
INSM
$33.7M
2
BPMC
Blueprint Medicines
BPMC
$32M
3
VTYX icon
Ventyx Biosciences
VTYX
$9.71M
4
LXEO icon
Lexeo Therapeutics
LXEO
$8.48M
5
ELVN icon
Enliven Therapeutics
ELVN
$8.02M

Top Sells

1
APGE icon
Apogee Therapeutics
APGE
$19.9M
2
SPY icon
SPDR S&P 500 ETF Trust
SPY
$16.8M
3
MRUS icon
Merus
MRUS
$13.3M
4
CNTA
Centessa Pharmaceuticals
CNTA
$8.5M
5
INZY
Inozyme Pharma
INZY
$8.47M

Sector Composition

1 Healthcare 95.02%
2 Financials 0.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALLK
76
DELISTED
Allakos
ALLK
– –
-250,000
Closed -$56.9K
ALNY icon
77
Alnylam Pharmaceuticals
ALNY
$59.4B
– –
0
– –
ALT icon
78
Altimmune
ALT
$314M
– –
0
– –
AMGN icon
79
Amgen
AMGN
$151B
– –
0
– –
BDTX icon
80
Black Diamond Therapeutics
BDTX
$163M
– –
-250,000
Closed -$388K
CAPR icon
81
Capricor Therapeutics
CAPR
$272M
– –
0
– –
CMPX icon
82
Compass Therapeutics
CMPX
$466M
– –
-130,807
Closed -$249K
CORT icon
83
Corcept Therapeutics
CORT
$7.31B
– –
0
– –
CRSP icon
84
CRISPR Therapeutics
CRSP
$4.8B
– –
0
– –
ETNB icon
85
89bio
ETNB
$1.28B
– –
-175,000
Closed -$1.27M
EWTX icon
86
Edgewise Therapeutics
EWTX
$1.54B
– –
0
– –
EXEL icon
87
Exelixis
EXEL
$10.1B
– –
0
– –
GALT icon
88
Galectin Therapeutics
GALT
$299M
– –
0
– –
IBRX icon
89
ImmunityBio
IBRX
$2.26B
– –
0
– –
IMVT icon
90
Immunovant
IMVT
$2.81B
– –
-430,000
Closed -$7.35M
INMB icon
91
INmune Bio
INMB
$51M
– –
0
– –
IWM icon
92
iShares Russell 2000 ETF
IWM
$67.4B
– –
0
– –
KPTI icon
93
Karyopharm Therapeutics
KPTI
$58.4M
– –
0
– –
KYMR icon
94
Kymera Therapeutics
KYMR
$3.02B
– –
-100,000
Closed -$2.74M
MGTX icon
95
MeiraGTx Holdings
MGTX
$621M
– –
-150,000
Closed -$1.02M
NBIX icon
96
Neurocrine Biosciences
NBIX
$13.9B
– –
-50,000
Closed -$5.53M
NVAX icon
97
Novavax
NVAX
$1.27B
– –
0
– –
OMER icon
98
Omeros
OMER
$284M
– –
-9,958
Closed -$81.9K
SLNO icon
99
Soleno Therapeutics
SLNO
$3.7B
– –
-50,000
Closed -$3.57M
SPY icon
100
SPDR S&P 500 ETF Trust
SPY
$662B
– –
-30,000
Closed -$16.8M
1 2 3
4
5